Lower Limb Paralysis Associated with Chikungunya in Kinshasa, the Democratic Republic of the Congo: Survey Report.
Mathy Matungala-PafubelJunior Bulabula-PengeMeris Matondo-KuamfumuSamy EsalaFrançois Edidi-AtaniElisabeth Pukuta-SimbuPaul Tshiminyi-MunkambaYannick Tutu Tshia N'kasarTrésor KatangaEtienne Ndomba-MukanyaDelphine Mbonga-MandeLionel Baketana-KinzonziEddy Kinganda LusamakiDaniel MukadiFabrice Mambu-MbikaPlacide Mbala-KingebeniEdith Nkwembe-NgabanaAntoine Nkuba-NdayeDaniel Okitundu-LuwaSteve Ahuka-MundekePublished in: Pathogens (Basel, Switzerland) (2024)
Polio-associated paralysis is one of the diseases under national surveillance in the Democratic Republic of the Congo (DRC). Although it has become relatively rare due to control measures, non-polio paralysis cases are still reported and constitute a real problem, especially for etiological diagnosis, which is necessary for better management and response. From September 2022 to April 2023, we investigated acute flaccid paralysis (AFP) cases in Kinshasa following an alert from the Provincial Division of Health. All suspected cases and their close contacts were investigated and sampled. Among the 57 sampled patients, 21 (36.8%) were suspects, and 36 (63.2%) were contacts. We performed several etiological tests available in the laboratory, targeting viruses, including Poliovirus, Influenza virus, SARS-CoV-2, Enterovirus, and arboviruses. No virus material was detected, but the serological test (ELISA) detected antibodies against Chikungunya Virus, i.e., 47.4% (27/57) for IgM and 22.8% (13/57) for IgG. Among suspected cases, we detected 33.3% (7/21) with anti-Chikungunya IgM and 14.3% (3/21) of anti-Chikungunya IgG. These results highlight the importance of enhancing the epidemiological surveillance of Chikungunya.
Keyphrases
- zika virus
- aedes aegypti
- dengue virus
- lower limb
- sars cov
- public health
- end stage renal disease
- healthcare
- ejection fraction
- newly diagnosed
- pulmonary embolism
- liver failure
- prognostic factors
- chronic kidney disease
- atomic force microscopy
- quality improvement
- patient reported outcomes
- mass spectrometry
- health information
- cross sectional
- drug delivery
- peritoneal dialysis
- respiratory syndrome coronavirus
- social media
- clinical decision support
- coronavirus disease
- monoclonal antibody